​Dr. Chris Apfel is the President and CEO of SageMedic Corp.  He co-founded SageMedic with his wife, Dr. Brigitte Apfel, after several of their family members have been touched by cancer.  

Chris is a physician-scientist, an active angel investor and a board member of over a dozen early stage life-science companies.  He is recognized as an international authority on designing, conducting, and publishing clinical trials that have changed medical practice. For example, he is the developer of the “Apfel Score,” a standard tool that has changed clinical practice world-wide.  He is a California-licensed physician and received his MD and his doctoral degree in medical sciences from the University of Giessen, Germany, and his MBA from Wharton, University of Pennsylvania.

Co-Founder and President & CEO

Melissa Ross, MBA

Melissa Ross is our SVP of Business Operations.  She is an accomplished senior executive with a 25-year track record of growing healthcare information technology companies.  Previously, was the Chief Operating Officer of VisiQuate and prior to that co-founded the Bishop Ranch Intelligence Innovation Accelerator (BRIIA).  Before that she held various other positions as a VP at MedeAnalytics, which she helped the company grow from a start-up to over $115 million in annual revenues.  Melissa holds a BS in Mathematics from Loyola University Maryland and an MBA from Saint Mary’s College of California.

Senior Vice President

Mona Wood, MD, PhD

Dr. Mona Wood is the medical lab director overseeing quality control and establishing SageMedic's CLIA certification. She is a Stanford trained pathologist with over 15 years of experience in biomedical research in a variety of scientific fields including gene therapy, protein structure and computational chemistry. She has earned numerous research awards and grants, including an independent early-investigator training award from NIH’s National Cancer Institute.  Dr. Wood has served as an elected chief resident in pathology informatics for two academic years at Stanford and is a graduate of Stanford’s Biodesign Innovation course. She majored in Chemistry, Biochemistry and French at the University of Michigan and received her MD and PhD in Chemistry from the University of California, Irvine.

Medical Lab Director

Brigitte Apfel, MD

Dr. Brigitte Apfel, is the co-founder and treasurer of SageMedic and she is a pulmonologist who has treated many lung cancer patients in the past, who became also a UCSF-trained psychiatrist when she and her husband moved to the bay area.  When family members have been affected by cancer, she and her husband decided to co-founded SageMedic.  Brigitte received her MD from the Ruprecht Karl University of Heidelberg in Germany.

Co-founder & Treasurer

William Werkmeister, MPA, MBA, Director of the Board

William Werkmeister, MPA, MBA is a Board Director of SageMedic. 

Bill is a Founding Partner of the International Cancer Impact Fund, as well as a member of the Advisory Board of the National Foundation for Cancer Research. Bill also co-founded a mobile breast tomosynthesis business and founded a series of state-subsidized impact venture funds called Aegis Venture as well as serving as AVP of Newtek/The Wilshire Group’s venture funds. Earlier in his career, Bill was an investment banker at Salomon Smith Barney and Citigroup Global Markets. Bill holds a BS in finance from Cornell, an MPA from Harvard, and an MBA from Yale.

Director of the Board

Bernard Rudnick, Director of the Board

Bernard C. Rudnick became a Board Member for SageMedic in January of 2018. Mr. Rudnick is the founder and Managing Partner of CapGenic Advisors, LLC, Chief Business Officer of NovoBioPharma, and a member of several angel groups. Mr. Rudnick’s entrepreneurial career includes several startups, three of which grew to over $60 million in revenue. He is a founder of one of the nation’s leading entrepreneurial programs (MADV) at the Fox School of Business, a director of Otosound, director and CFO of Immunomic Therapeutics, and has held several other board positions.

With 36 years of experience in executive-level strategy, finance, and management, Mr. Rudnick has senior merger, acquisition, capital formation and licensing leadership experience with companies ranging from start-up to Fortune 50. Mr. Rudnick currently advises companies in the clinical software, therapeutic, medical device, and in the cell line engineering areas. His advisory clients have included Mitsui (Mitrix), DuPont (Agri-chemical), McKesson Bioservices (now TMO), Kika Clinical Solutions (now MRGE) as well as several early stage life sciences companies. Angel group affiliations include Minority Angel Investment Network, a founder of Mid-Atlantic Bio Angels and Keiretsu Mid-Atlantic.

Board Member

Please reload

This website is not for investment purposes. Contact the company for investing documents.

Copyright © 2019 SageMedic Corporation. All rights reserved.